Circulating Human Papillomavirus DNA-Liquid Biopsy in Head and Neck Cancers.
This publication reviews the current evidence on circulating tumor HPV DNA (ctHPVDNA) as a liquid biopsy tool in human p...
Percutaneous endoscopic gastrostomy improves survival and nutritional outcomes in patients with head and neck cancer.
- Post category:Head & Neck Cancers
- Reading time:1 min read
This retrospective cohort study evaluated the impact of percutaneous endoscopic gastrostomy (PEG) on patients with head...
Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccines.
- Post category:Head & Neck Cancers
- Reading time:1 min read
This review focuses on nasopharyngeal carcinoma (NPC), particularly in regions where it is endemic and closely linked to...
Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial.
- Post category:Head & Neck Cancers
- Reading time:1 min read
This phase II neoCHANCE-1 study evaluated neoadjuvant dual blockade of PD-1 and EGFR pathways using tislelizumab and afa...
HPV Workshop for Underserved High School Students.
- Post category:Head & Neck Cancers
- Reading time:1 min read
This study addresses the rising incidence of HPV-related oropharyngeal cancer and persistent disparities in HPV vaccinat...
The Immunotherapy Clock Has Moved
- Post category:Breast Cancer/Genitourinary (Prostate, Bladder) System/Head & Neck Cancers/Pan Cancer/Respiratory (Lung, Bronchus) System/Supportive Oncology/Survivorship
- Reading time:3 mins read
Checkpoint inhibitors are no longer reserved for late-stage salvage. The clearest signal from recent meetings and trials is this: the greatest survival benefit may be increasingly found in neoadjuvant and perioperative settings. This…